Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
4
×
boston blog main
national blog main
biotech
cancer
clinical trials
gilead sciences
san francisco blog main
san francisco top stories
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
andrew berens
anirvan ghosh
astrazeneca
avapritinib
biogen
blueprint medicines
bluerock therapeutics
boston
boulder/denver blog main
boulder/denver top stories
business
cancer diagnostics
cancer immunotherapy
cerovene
covid-19
crispr
deals
deciphera pharmaceuticals
deerfield management
detroit blog main
detroit top stories
durvalumab
editas medicine
entrepreneur
europe blog main
What
announced
4
×
plans
4
×
based
cancer
firm
medicine
sciences
acquisitions
adding
adds
approval
area
banks
bay
bio
biopsy
blood
blueprint
buildout
california
capital
ceo
chasing
close
collabs
company
covid
daniel
deadly
deal
decided
deciphera
developing
dive
driven
drug
fda
filing
forms
genomic
Language
unset
Current search:
plans
×
announced
×
" life sciences "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@venturebeat.com
6 years ago
Menlo Ventures banks on tech-driven life sciences, adds Greg Yap as new partner
